Abbott, a leader in diabetes tech with ... announced this week that it's issuing a voluntary medical device correction for ...

The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above ...

Abbott's FreeStyle Libre Flash Glucose Monitoring System allows patients to measure their blood glucose levels without fingerpricks or test strips. The system consists of a small sensor that is worn ...

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.